News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection
November 5, 2024
·
5 min read
Press Releases
Defence Announces Extension of Private Placement, Continues Development of Its Radiopharmaceuticals and ADC Programs
November 5, 2024
·
2 min read
Press Releases
Adaptimmune to Participate in Scientific and Medical Conferences this November and December
November 5, 2024
·
4 min read
Press Releases
AquaBounty Technologies Announces Third Quarter 2024 Financial Results
November 5, 2024
·
12 min read
Press Releases
PharmaDrug Announces Proposed Issuance of Debenture Units
November 1, 2024
·
5 min read
Press Releases
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
November 1, 2024
·
4 min read
Press Releases
Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
October 31, 2024
·
2 min read
Press Releases
Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement
October 31, 2024
·
10 min read
Press Releases
PharmaDrug’s Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases
October 31, 2024
·
7 min read
Press Releases
Defence Therapeutics Completes 1st Tranche of Financing
October 31, 2024
·
4 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us